Proton Magnetic Resonance Spectroscopy: Ex vivo study to investigate its prognostic role in colorectal cancer - 01/10/13
, Pasquina Marzola b, Alice Ferretti c, d, Anna Margherita Maffione c, Andrea Sboarina a, Maria Bencivenga a, Federico Boschi b, Giamaica Conti b, Andrea Sbarbati bBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Background |
Proton Magnetic Resonance Spectroscopy (1H MRS) is used for clinical diagnosis in some tumours. The aim of this study is to explore ex vivo the potential of 1H MRS in identifying malignancy through metabolic markers in the perspective of its application in all cases of difficult diagnosis and after neoadjuvant treatment.
Methods |
Spectroscopy was performed ex vivo on 29 colorectal specimens. All patients were staged with imaging, underwent radical surgery and then followed-up. Spectral quantification analysis of components expressed in colorectal tumours and in healthy mucosa were evaluated. The MRS-tumour marker (MRS-tm) was calculated for each case. The U-test was used to compare MRS-tm in tumours and in healthy mucosa. In order to select a cut-off for MRS-tm in the tumour and healthy mucosa and to distinguish patients who were disease-free or with recurrence-progression, we performed the ROC curve analysis.
Results |
In the 24 subjects without neoadjuvant treatment, it was found that MRS-tm is able to discriminate healthy and neoplastic tissue and can discriminate patients with risk of recurrence/progression
Conclusion |
Our data seem to show that 1H MRS may be successfully applied in vivo non-invasively to differentiate tumours from healthy mucosa and could also distinguish patients with different prognoses.
Le texte complet de cet article est disponible en PDF.Keywords : Colorectal cancer, 1H MRS, Tumor metabolism, Choline, Lipids
Plan
Vol 67 - N° 7
P. 593-597 - septembre 2013 Retour au numéro
Article précédent
- Mechanisms of anti-leukemic activity of the Bcl-2 homology domain-3 mimetic S1
- Yubo Liu, Zhiqiang Li, Ting Song, Zuguang Xue, Zhichao Zhang
- The antiangiogenic activity of a soluble fragment of the VEGFR extracellular domain
- Haixin Li, Wanlu Cao, Zhiguo Chen, Desmond Omane Acheampong, Haizhen Jin, Daojuan Li, Juan Zhang, Min Wang
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?